← Eichor
Condition: Epidermolysis Bullosa Simplex Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Epidermolysis Bullosa Simplex

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A 44-week Monocentric Open Study Assessing the Efficacy and Safety of Deucravacitinib in Adults With Inflammatory Genode
Phase 2 · 2 location(s) · Centre Hospitalier Universitaire de Nice · NCT06136403A 20-Week Study Assessing the Efficacy of Apremilast in Patients with EB Simplex Generalized
Phase 2 · 4 location(s) · Centre Hospitalier Universitaire de Nice · NCT06509984A Phase II, Placebo Controlled, Clinical Trial of Topical TolaSure Targeting Aggregated Mutant Keratin in Epidermolysis
Phase 2 · 2 location(s) · BioMendics, LLC · NCT07027345
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.